Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Barney Graham

Professor

Morehouse School of Medicine

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (11)

Tongqing Zhou

Principal Investigator

National Institutes of Health

UNITED STATES

View details

Hyon Xhi Tan

University of Melbourne

AUSTRALIA

View details

Benjamin Treat

Staff Scientist

University of Pittsburgh

UNITED STATES

View details

Larance Ronsard

Senior Research Scientist

Ragon Institute of MGH, MIT and Harvard

UNITED STATES

View details

PRISCILA CASTANHA

Assistant Professor

University of Pittsburgh

UNITED STATES

View details

Douglas Reed

University of Pittsburgh

UNITED STATES

View details

Donald Latner

Senior Scientist

HudsonAlpha Institute for Biotechnology

UNITED STATES

View details

Fabian Lean

City University of Hong Kong

HONG KONG

View details

Jason S. McLellan

University of Texas at Austin

UNITED STATES

View details

Tracy Ruckwardt

National Institutes of Health

UNITED STATES

View details

Andrew Borst

Senior Scientist & Head of Electron Microscopy

University of Washington

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Barney Graham

Research Interests

Make your next move.

Explore related searches

Articles (20)

Full-length premembrane protein is not required for mature Zika virus particle assembly

Potent Monoclonal Antibodies Against Circulating Yellow Fever Virus Strains from Donors Immunized with the 17D Vaccine

Selective Budding of SARS-CoV-Like Particles from Glycolipid-Enriched Membrane Lipid Rafts and Host Gene Modulation

Pre-exposure antibody prophylaxis protects macaques from severe influenza

Safety, Immunogenicity, and Protective Efficacy in Rhesus Macaques of a Novel Recombinant Hemagglutinin Protein Measles Virus Vaccine

MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies

Evaluation of a nanoparticle influenza vaccine in the pig model

Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies

Decoding respiratory syncytial virus morphology: distinct structural and molecular signatures of spherical and filamentous particles

Host RhoA Signaling Controls Filamentous vs. Spherical Morphogenesis and Cell-to-Cell Spread of RSV via Lipid Raft Localization: Host-Directed Antiviral Target

Novel Human Antibody-Secreting Cell (ASC) Culture Systems to Determine Vaccine Durability

Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines

Prefusion stabilization of the Hendra and Langya virus F proteins

Structure-based design of glycoprotein subunit vaccines for mumps

Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem

Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials

Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodies

Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine

Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase

Collaborators (11)

Tongqing Zhou

Hyon Xhi Tan

Benjamin Treat

Larance Ronsard

PRISCILA CASTANHA

Douglas Reed

Donald Latner

Fabian Lean

Jason S. McLellan

Tracy Ruckwardt

Andrew Borst

Make your next move.